Parx Plastics specializes in the development, manufacturing and marketing of biocompatible plastics and antibacterial polymers. The company’s technology does not feature synthetic chemicals, biocides, heavy metals or nanoparticles. It can be used with any type of plastic. It is fully biocompatible, non-toxic, and does not diffuse out of the material. Also, it removes about 99% of bacteria and microorganisms pilling up on the surface of a product within 24 hours.
Parx Plastics N.V. celebrates a private placement on Euronext Access in Paris.
Michael van der Jagt, CEO of Parx Plastics N.V. opens the Paris trading day.